Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Rituximab-based chemotherapy achieves strong outcomes without routine radiotherapy in stage I extranodal large B-cell lymphoma

Dr Konstantinos Christofyllakis - Saarland University, Saarbrücken, Germany
Rituximab-based chemotherapy achieves strong outcomes without routine radiotherapy in stage I extranodal large B-cell lymphoma ( Dr Konstantinos Christofyllakis - Saarland University, Saarbrücken, Germany )
30 Mar 2026

Epcoritamab plus rituximab and lenalidomide improves efficacy in relapsed or refractory follicular lymphoma

Dr Lorenzo Falchi - Memorial Sloan Kettering Cancer Center, New York, USA
Epcoritamab plus rituximab and lenalidomide improves efficacy in relapsed or refractory follicular lymphoma ( Dr Lorenzo Falchi - Memorial Sloan Kettering Cancer Center, New York, USA )
24 Feb 2026

Climate and environmental factors drive seasonal risk of invasive mucormycosis in haematologic malignancies

Dr Thomas Kuczmarski - Fred Hutchinson Cancer Center, Seattle, USA
Climate and environmental factors drive seasonal risk of invasive mucormycosis in haematologic malignancies ( Dr Thomas Kuczmarski - Fred Hutchinson Cancer Center, Seattle, USA )
5 Feb 2026

Extreme heat exposure around diagnosis is linked to higher mortality in multiple myeloma

Dr Thomas Kuczmarski - Fred Hutchinson Cancer Center, Seattle, USA
Extreme heat exposure around diagnosis is linked to higher mortality in multiple myeloma ( Dr Thomas Kuczmarski - Fred Hutchinson Cancer Center, Seattle, USA )
5 Feb 2026

Mismatching of unrelated donors beyond a single HLA-locus does not adversely impact outcomes following transplantation

Dr Antonio Jimenez Jimenez - Sylvester Comprehensive Cancer Center, Miami, USA
Mismatching of unrelated donors beyond a single HLA-locus does not adversely impact outcomes following transplantation ( Dr Antonio Jimenez Jimenez - Sylvester Comprehensive Cancer Center, Miami, USA )
15 Jan 2026

MS-553 shows promise in treating chronic lymphocytic leukaemia

Prof Jennifer Woyach - The Ohio State University, Columbus, USA
MS-553 shows promise in treating chronic lymphocytic leukaemia ( Prof Jennifer Woyach - The Ohio State University, Columbus, USA )
15 Jan 2026

Liso-cel in r/r follicular lymphoma shows durable 3-year responses and favourable long-term safety

Dr Sairah Ahmed - MD Anderson Cancer Network, Houston, USA
Liso-cel in r/r follicular lymphoma shows durable 3-year responses and favourable long-term safety ( Dr Sairah Ahmed - MD Anderson Cancer Network, Houston, USA )
8 Jan 2026

TKI chemotherapy and ponatinib improve survival outcomes in blast phase CML

Dr Akriti Jain - Cleveland Clinic, Cleveland, USA
TKI chemotherapy and ponatinib improve survival outcomes in blast phase CML ( Dr Akriti Jain - Cleveland Clinic, Cleveland, USA )
8 Jan 2026

Consolidation treatment delays do not compromise survival in MRD-negative adult ALL

Prof Bhavana Bhatnagar - WVU Medicine Wheeling Hospital, Wheeling, USA
Consolidation treatment delays do not compromise survival in MRD-negative adult ALL ( Prof Bhavana Bhatnagar - WVU Medicine Wheeling Hospital, Wheeling, USA )
7 Jan 2026

Non-TBI conditioning achieves positive results in MRD-negative CAYA B-ALL undergoing allogeneic HCT

Prof Hisham Abdel-Azim - Loma Linda University, Loma Linda, USA
Non-TBI conditioning achieves positive results in MRD-negative CAYA B-ALL undergoing allogeneic HCT ( Prof Hisham Abdel-Azim - Loma Linda University, Loma Linda, USA )
22 Dec 2025

Dasatinib, prednisone, and blinatumomab combination shows promising outcomes in elderly patients with Ph+ ALL

Dr Anjali Advani - Cleveland Clinic, Cleveland, USA
Dasatinib, prednisone, and blinatumomab combination shows promising outcomes in elderly patients with Ph+ ALL ( Dr Anjali Advani - Cleveland Clinic, Cleveland, USA )
19 Dec 2025

Blinatumomab plus chemotherapy shows manageable toxicity in adults with Ph- B-ALL

Dr Anjali Advani - Cleveland Clinic, Cleveland, USA
Blinatumomab plus chemotherapy shows manageable toxicity in adults with Ph- B-ALL ( Dr Anjali Advani - Cleveland Clinic, Cleveland, USA )
19 Dec 2025